Farrier, A J <br/><br/>
New anti-resorptives and antibody mediated anti-resorptive therapy.  [electronic resource] 

 -  The bone & joint journal  Feb 2016 
 - 160-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>2049-4408 
<br/><br/><label>Standard No.: </label>10.1302/0301-620X.98B2.36161  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adaptor Proteins, Signal Transducing<br/>Antibodies, Monoclonal, Humanized--pharmacology<br/>Bisphosphonate-Associated Osteonecrosis of the Jaw--etiology<br/>Bone Density Conservation Agents--pharmacology<br/>Bone Morphogenetic Proteins--antagonists & inhibitors<br/>Bone Neoplasms--drug therapy<br/>Bone Resorption--drug therapy<br/>Cost-Benefit Analysis<br/>Denosumab--pharmacology<br/>Diphosphonates--therapeutic use<br/>Drug Approval<br/>Femoral Fractures--chemically induced<br/>Genetic Markers<br/>Humans<br/>Hypocalcemia--chemically induced<br/>Osteoporosis--drug therapy<br/>Osteoporotic Fractures--drug therapy<br/>Practice Guidelines as Topic<br/>Quality-Adjusted Life Years<br/>RANK Ligand--antagonists & inhibitors